Mesangial deposits of monoclonal kappa/Lambda light chains in indicative of:
💡 Explanation
## **Core Concept**
The question tests knowledge on the specific types of renal pathology associated with monoclonal light chain deposits. Monoclonal kappa or lambda light chains can accumulate in various renal structures, leading to distinct clinicopathological entities. Understanding the specific locations and types of light chain deposits is crucial for diagnosing conditions such as light chain deposition disease.
## **Why the Correct Answer is Right**
The correct answer, **C. Light Chain Deposition Disease (LCDD)**, is associated with the deposition of monoclonal light chains (kappa or lambda) primarily in the mesangium and along the glomerular and tubular basement membranes. This condition leads to the disruption of normal renal architecture and function. The mesangial deposits of monoclonal kappa or lambda light chains are characteristic and contribute to the diagnosis.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not specify a condition known for mesangial deposits of monoclonal kappa/lambda light chains.
- **Option B:** This option is incorrect as it does not accurately represent a condition characterized by such specific light chain deposits in the mesangium.
- **Option D:** This option is incorrect because it does not correspond with the described pathological findings.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that Light Chain Deposition Disease (LCDD) often presents with systemic manifestations and renal involvement, including proteinuria and renal failure. The presence of monoclonal light chains in the urine (Bence Jones proteins) or serum can support the diagnosis.